Journal of Cell Biology and Metabolism

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Cell Biology and Metabolism (2024) Volume 6, Issue 5

Ribosomes: The Protein Factories of the Cell

Bruno Amedur*

Department of Biology, University of Western Brittany, France.

*Corresponding Author:
Bruno Amedur
Department of Biology
University of Western Brittany, France.
E-mail: amedur@enscm.fr

Received: 03-Oct-2024, Manuscript No. AACBM-24-149378; Editor assigned: 04-Oct-2024, PreQC No. AACBM-24-1493785(PQ); Reviewed: 18-Oct-2024, QC No AACBM-24-1493785; Revised: 22-Oct-2024, Manuscript No. AACBM-24-1493785(R); Published: 28-Oct-2024, DOI:10.35841/aacbm-6.5.228

Citation: Amedur B. Ribosomes: The protein factories of the cell. J Cell Biol Metab. 2024;6(5):228.

Visit for more related articles at Journal of Cell Biology and Metabolism

Abstract

  

Introduction

Ribosomes are essential cellular structures responsible for synthesizing proteins, which are vital for numerous biological functions. Found in all living organisms, ribosomes play a crucial role in translating genetic information into functional proteins. Their complex architecture and intricate functioning are fundamental to cellular life, making them a focal point of study in molecular biology and biochemistry [1].

Ribosomes are assembled in a process that occurs in the nucleolus of eukaryotic cells and the cytoplasm of prokaryotic cells. The synthesis of rRNA occurs first, followed by the binding of ribosomal proteins. Once assembled, ribosomes can either remain free in the cytoplasm or attach to the endoplasmic reticulum (ER), forming rough ER.

Ribosomes are primarily known for their role in protein synthesis, a process that can be divided into three main stages: initiation, elongation, and termination [2].

The initiation phase begins when the small ribosomal subunit (30S in prokaryotes and 40S in eukaryotes) binds to the mRNA molecule. In eukaryotes, the ribosome recognizes the 5' cap of the mRNA, while in prokaryotes, the ribosome binds to specific sequences in the mRNA known as Shine-Dalgarno sequences.

In eukaryotes, initiation factors help assemble the ribosomal subunits and the mRNA. In prokaryotes, initiation factors also assist in this process but are somewhat different in structure and function [3].

The first aminoacyl-tRNA, carrying the amino acid methionine (AUG start codon), enters the ribosome's P site, forming a complete initiation complex. during the elongation phase, the ribosome moves along the mRNA, adding amino acids to the growing polypeptide chain.

Each new aminoacyl-tRNA, corresponding to the next codon in the mRNA sequence, enters the ribosome's A site. Elongation factors assist in this process, ensuring that the correct tRNA binds [4].

The ribosome catalyzes the formation of peptide bonds between the amino acids. This reaction is facilitated by the rRNA in the large subunit, demonstrating the ribosome's dual role as both a structural and catalytic entity.

Once the peptide bond is formed, the ribosome moves one codon along the mRNA. The tRNA in the P site is shifted to the E site, where it exits the ribosome, while the tRNA in the A site moves to the P site, making way for a new aminoacyl-tRNA to enter the A site [5].

The termination phase occurs when the ribosome encounters a stop codon (UAA, UAG, or UGA) on the mRNA.

Proteins known as release factors bind to the ribosome in response to the stop codon, promoting the hydrolysis of the bond between the polypeptide and the tRNA in the P site.

The ribosomal subunits, mRNA, and newly synthesized polypeptide dissociate, allowing the ribosomal components to be recycled for future rounds of translation [6].

The process of translation is guided by the genetic code, a set of rules that determine how sequences of nucleotide triplets (codons) in mRNA are translated into amino acids.

Each codon in mRNA corresponds to a specific amino acid, with the genetic code being nearly universal across all organisms. tRNA molecules have complementary anticodons that pair with the codons in the mRNA, ensuring that the correct amino acids are incorporated into the growing polypeptide chain [7].

The wobble hypothesis explains how a single tRNA can recognize multiple codons that code for the same amino acid. This flexibility in base pairing allows for a degree of redundancy in the genetic code, enhancing the efficiency of protein synthesis.

While the fundamental process of translation is similar in prokaryotes and eukaryotes, there are notable differences in ribosomal structure, function, and regulation [8].

Prokaryotic ribosomes (70S) are smaller than eukaryotic ribosomes (80S) and have different sedimentation coefficients. The structural differences extend to the rRNA and protein components, with prokaryotic ribosomes having distinct sequences and arrangements compared to eukaryotic ribosomes.

In prokaryotes, transcription and translation occur simultaneously in the cytoplasm, allowing for rapid protein synthesis. As soon as mRNA is synthesized, ribosomes can attach and begin translation. In eukaryotes, transcription occurs in the nucleus, and mRNA must be processed (capped, polyadenylated, and spliced) before it is exported to the cytoplasm for translation [9].

Eukaryotic translation is more tightly regulated than prokaryotic translation. Various initiation factors and regulatory proteins modulate the efficiency of translation in response to cellular conditions. In contrast, prokaryotic translation can be more straightforward, with fewer regulatory mechanisms.

Ribosomes are a target for many antibiotics, which exploit the differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial protein synthesis without affecting human cells.

These antibiotics inhibit the binding of aminoacyl-tRNA to the A site of the ribosome, preventing the incorporation of new amino acids into the polypeptide chain.

These antibiotics bind to the 50S subunit, inhibiting peptide bond formation and blocking elongation of the protein chain [10].

Conclusion

In muscle cells, ribosomes are abundant and actively engaged in protein synthesis, supporting the high metabolic demands associated with contraction and growth.

In cells specialized for secretion, such as pancreatic cells, ribosomes are primarily associated with the rough ER. These cells synthesize large quantities of proteins (like enzymes and hormones) that are secreted into the bloodstream.

In neurons, ribosomes are crucial for synthesizing proteins involved in neurotransmission, including receptors and signaling molecules. Localized translation in dendrites allows for rapid responses to synaptic activity.

Ribosomes in stem cells exhibit unique properties, allowing for the rapid production of proteins required for differentiation and self-renewal. Regulation of translation is tightly controlled in these cells to maintain pluripotency.

References

  1. Barnes LM, Dickson AJ. Mammalian cell factories for efficient and stable protein expression. Curr Opin Biotechnol. 2006;17(4):381-6.

    2. Indexed at, Google Scholar, Cross Ref

  2. Kermode AR. Plants as factories for production of biopharmaceutical and bioindustrial proteins: lessons from cell biology. Botany. 2006;84(4):679-94.

    3. Indexed at, Google Scholar, Cross Ref

  3. Xu N, Liu Y, Jiang H, et al. Combining protein and metabolic engineering to construct efficient microbial cell factories. Curr Opin Biotechnol. 2020;66:27-35.

    4. Indexed at, Google Scholar, Cross Ref

  4. Zhou P, Gao C, Song W, et al. Engineering status of protein for improving microbial cell factories. Biotechnol Adv. 2024;70:108282.

    5. Indexed at, Google Scholar, Cross Ref

  5. Mayfield SP, Manuell AL, Chen S, et al. Chlamydomonas reinhardtii chloroplasts as protein factories. Curr Opin Biotechnol. 2007;18(2):126-33.

    6. Indexed at, Google Scholar, Cross Ref

  6. Punt PJ, van Biezen N, Conesa A, et al. Filamentous fungi as cell factories for heterologous protein production. Trends Biotech. 2002;20(5):200-6.

    7. Indexed at, Google Scholar, Cross Ref

  7. Saei AA, Ghanbari P, Barzegari A. Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins. Mol Biol Rep. 2012;39:9931-9.

    8. Indexed at, Google Scholar, Cross Ref

  8. Bachhav B, de Rossi J, Llanos CD, et al. Cell factory engineering: Challenges and opportunities for synthetic biology applications. Biotechnol Bioeng. 2023;120(9):2441-59.

    9. Indexed at, Google Scholar, Cross Ref

  9. Rong Y, Jensen SI, Lindorff-Larsen K, et al. Folding of heterologous proteins in bacterial cell factories: Cellular mechanisms and engineering strategies. Biotechnol Adv. 2023;63:108079.

    10. Indexed at, Google Scholar, Cross Ref

  10. Sauer M, Mattanovich D. Construction of microbial cell factories for industrial bioprocesses. J Chem Technol Biotechnol. 2012;87(4):445-50.

    11. Indexed at, Google Scholar, Cross Ref

Get the App